Clinic
Planned Parenthood Los Angeles - East Los Angeles Center
Planned Parenthood Los Angeles - East Los Angeles Center was paid $5.18M by Medicaid between Jan 2018 and Dec 2024, across 38 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 14% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD LOS ANGELES - EAST LOS ANGELES CENTER
LOS ANGELES, CA 90022
LOS ANGELES, CA 90022
33aNPI1720256647assigned 02/13/2008
33bProvider typeCommunity Health Clinic/Center
28Total paid$5.18M
24GClaims126,115
24DCodes billed38
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community Health Clinic/Center providers in California
Rank by total paid#82 of 288
Median peer was paid$2.15M
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PAHL, LINDA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,806 | $1.39M | |
| 2019 | 17,492 | $767K | |
| 2020 | 13,295 | $528K | |
| 2021 | 18,065 | $744K | |
| 2022 | 14,650 | $535K | |
| 2023 | 18,407 | $695K | |
| 2024incomplete | 15,400 | $523K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 14% | 14,015 | 12,926 | $745K |
| J3490 | Unclassified drugs | 13% | 19,901 | 16,766 | $673K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 5,190 | 4,852 | $658K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 10% | 5,820 | 5,596 | $529K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 8.9% | 500 | 500 | $459K |
| S4993 | Contraceptive pills for birth control | 6.7% | 3,813 | 3,777 | $350K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 5.7% | 1,517 | 1,474 | $293K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.6% | 753 | 726 | $241K |
| 87806 | 4.3% | 8,949 | 7,026 | $220K | |
| 99201 | 4.2% | 1,751 | 1,605 | $218K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.9% | 726 | 667 | $149K |
| 11981 | 2.1% | 472 | 472 | $111K |
26 more codes
| J7304 | Contraceptive supply, hormone containing patch, each | 2.1% | 377 | $106K |
| A4267 | Contraceptive supply, condom, male, each | 1.7% | 15,195 | $90K |
| 81025 | 1.1% | 17,204 | $56K | |
| 11976 | <1% | 738 | $42K | |
| 99401 | <1% | 1,958 | $37K | |
| S5000 | Prescription drug, generic | <1% | 4,225 | $28K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 2,078 | $26K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 308 | $23K |
| 58300 | <1% | 255 | $22K | |
| 99000 | <1% | 5,341 | $19K | |
| 83986 | <1% | 5,331 | $14K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 3,442 | $13K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 31 | $12K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 579 | $10K |
| 86703 | <1% | 942 | $10K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 572 | $10K |
| 58301 | <1% | 186 | $5K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 1,141 | $4K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 206 | $3K |
| 81002 | <1% | 1,419 | $3K | |
| 86592 | <1% | 823 | $2K | |
| 99402 | <1% | 14 | $445.06 | |
| 82120 | <1% | 123 | $358.60 | |
| 87210 | <1% | 122 | $331.17 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 63 | $326.65 |
| 99070 | <1% | 35 | $0.03 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPAHL, LINDA (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.